Showing 1 - 20 results of 50 for search 'Yu V Muravyev', query time: 0.04s Refine Results
  1. 1
    WHAT ADVERSE REACTIONS TO BIOLOGICAL AGENTS ARE PARADOXICAL?

    WHAT ADVERSE REACTIONS TO BIOLOGICAL AGENTS ARE PARADOXICAL? by Yu. V. Muravyev

    Published 2018-09-01
    Get full text
    Article
  2. 2
    EXTRA-ARTICULAR MANIFESTATIONS OF RHEUMATOID ARTHRITIS

    EXTRA-ARTICULAR MANIFESTATIONS OF RHEUMATOID ARTHRITIS by Yu. V. Muravyev

    Published 2018-07-01
    Get full text
    Article
  3. 3
    WHY IS THE STUDY OF THE COMPLEX SAFETY OF CELECOXIB FOR ARTHRITIS, WHICH IS CALLED PRECISION, LAST BUT NOT LEAST?

    WHY IS THE STUDY OF THE COMPLEX SAFETY OF CELECOXIB FOR ARTHRITIS, WHICH IS CALLED PRECISION, LAST BUT NOT LEAST? by Yu. V. Muravyev

    Published 2017-07-01
    Get full text
    Article
  4. 4
    IS THE PATIENT PARTNERSHIP INFORMATIVE IN PHARMACOVIGILANCE?

    IS THE PATIENT PARTNERSHIP INFORMATIVE IN PHARMACOVIGILANCE? by Yu. V. Muravyev

    Published 2017-09-01
    Get full text
    Article
  5. 5
    NEW POSSIBILITIES FOR MONITORING METHOTREXATE EFFICACY IN RHEUMATOID ARTHRITIS

    NEW POSSIBILITIES FOR MONITORING METHOTREXATE EFFICACY IN RHEUMATOID ARTHRITIS by Yu. V. Muravyev

    Published 2015-09-01
    Get full text
    Article
  6. 6
    DIAGNOSTIC AND CLASSIFICATION CRITERIA IN RHEUMATOLOGY: WHEN SHOULD THE CRITERIA BE USED AND HOW DO THEY DIFFER?

    DIAGNOSTIC AND CLASSIFICATION CRITERIA IN RHEUMATOLOGY: WHEN SHOULD THE CRITERIA BE USED AND HOW DO THEY DIFFER? by Yu. V. Muravyev

    Published 2017-03-01
    Get full text
    Article
  7. 7
    Rheumatoid arthritis classification criteria: debatable problems

    Rheumatoid arthritis classification criteria: debatable problems by Yu. V. Muravyev, A. S. Misiyuk

    Published 2019-01-01
    Get full text
    Article
  8. 8
    CHARACTERISTICS OF ADULT-ONSET STILL’S DISEASE IN THE 21ST CENTURY

    CHARACTERISTICS OF ADULT-ONSET STILL’S DISEASE IN THE 21ST CENTURY by V. V. Lebedeva, Yu. V. Muravyev

    Published 2018-09-01
    Get full text
    Article
  9. 9
    The evolution of discussion ideas on drug-induced disease

    The evolution of discussion ideas on drug-induced disease by Yu. V. Muravyev, L. A. Muravyeva

    Published 2016-10-01
    Get full text
    Article
  10. 10
    ChTO DELAT'', ESLI V PERIOD LEChENIYa INGIBITORAMI FAKTORA NEKROZA OPUKhOLI α VOZNIK PSORIAZ?

    ChTO DELAT'', ESLI V PERIOD LEChENIYa INGIBITORAMI FAKTORA NEKROZA OPUKhOLI α VOZNIK PSORIAZ? by Yu. V. Muravyev, I. A. Doroshkevich

    Published 2011-06-01
    Get full text
    Article
  11. 11
    ADULT-ONSET STILL'S DISEASE TODAY

    ADULT-ONSET STILL'S DISEASE TODAY by Yu. V. Muravyev, V. V. Lebedeva

    Published 2017-07-01
    Get full text
    Article
  12. 12
    WHAT TO DO WITH A VARIETY OF TERMS THAT REFLECT THE HARM OF DRUGS?

    WHAT TO DO WITH A VARIETY OF TERMS THAT REFLECT THE HARM OF DRUGS? by Yu. V. Muravyev, L. A. Muravyeva

    Published 2017-04-01
    Get full text
    Article
  13. 13
    TARDY IDEAS ON THE USE OF BIOLOGICAL AGENTS IN RHEUMATIC DISEASES

    TARDY IDEAS ON THE USE OF BIOLOGICAL AGENTS IN RHEUMATIC DISEASES by Yu. V. Muravyev, L. A. Muravyeva

    Published 2016-07-01
    Get full text
    Article
  14. 14
    POTENTIAL HARMS OF THE USE OF PROTON PUMP INHIBITORS: DEBATABLE PROBLEMS

    POTENTIAL HARMS OF THE USE OF PROTON PUMP INHIBITORS: DEBATABLE PROBLEMS by Yu. V. Muravyev, O. R. Bobkova

    Published 2018-11-01
    Get full text
    Article
  15. 15
    XXI century: changes in the Erice Declaration on drug safety

    XXI century: changes in the Erice Declaration on drug safety by Yu. V. Muravyev, L. A. Muravyeva

    Published 2019-05-01
    Get full text
    Article
  16. 16
    WHY ARE THE RECOMMENDED METHOTREXATE DOSES NOT USED FOR THE TREATMENT OF RHEUMATOID ARTHRITIS: WHO IS GUILTY AND WHAT TO DO?

    WHY ARE THE RECOMMENDED METHOTREXATE DOSES NOT USED FOR THE TREATMENT OF RHEUMATOID ARTHRITIS: WHO IS GUILTY AND WHAT TO DO? by Yu. V. Muravyev, E. L. Nasonov

    Published 2017-03-01
    Get full text
    Article
  17. 17
    The problem of laboratory monitoring in therapy with disease-modifying antirheumatic drugs and biological agents in patients with rheumatoid arthritis

    The problem of laboratory monitoring in therapy with disease-modifying antirheumatic drugs and biological agents in patients with rheumatoid arthritis by Yu. V. Muravyev, L. A. Muravyeva

    Published 2018-09-01
    Get full text
    Article
  18. 18
    On the terms «rheumatology» and «rheumatic diseases» (regarding Sh. Erdes's article «Definition of the term «rheumatology»: do we need this and how do the EULAR and the ACR look at this?»)

    On the terms «rheumatology» and «rheumatic diseases» (regarding Sh. Erdes's article «Definition of the term «rheumatology»: do we need this and how do the EULAR and the ACR look at... by Yu. V. Muravyev, L. A. Muravyeva

    Published 2019-07-01
    Get full text
    Article
  19. 19
    DRUG SAFETY DATA COVERAGE IN MEDICAL LITERATURE

    DRUG SAFETY DATA COVERAGE IN MEDICAL LITERATURE by Yu. V. Muravyev, L. A. Muravyeva

    Published 2015-09-01
    Get full text
    Article
  20. 20
    DISCUSSION IDEAS ABOUT MEDICINE AMBIGUITIES

    DISCUSSION IDEAS ABOUT MEDICINE AMBIGUITIES by Yu. V. Muravyev, L. A. Muravyev

    Published 2017-10-01
    Get full text
    Article

Search Tools: